These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 712115

  • 21. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG, Gagarinova VM, Gorev NE, Shadrin AS.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [Abstract] [Full Text] [Related]

  • 22. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety.
    Wright PF, Cherry JD, Foy HM, Glezen WP, Hall CB, McIntosh K, Monto AS, Parrott RH, Portnoy B, Taber LH.
    Rev Infect Dis; 1983 Apr; 5(4):758-64. PubMed ID: 6353530
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 24. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 25. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A, Potter CW, Clark A, Jennings R, Schild GC, Yetts R.
    J Hyg (Lond); 1983 Feb 15; 90(1):107-15. PubMed ID: 6822725
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C, Hofmann H, Bachmayer H, Liehl E, Moritz AJ.
    Dev Biol Stand; 1983 Feb 15; 39():297-302. PubMed ID: 342311
    [Abstract] [Full Text] [Related]

  • 33. Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children.
    Eastwood LM, Jennings R, Milner RD, Potter CW.
    J Clin Pathol; 1979 Jun 15; 32(6):534-7. PubMed ID: 469010
    [Abstract] [Full Text] [Related]

  • 34. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR, Rizzone C, DeMello S, Ogra PL.
    Dev Biol Stand; 1976 Jun 15; 33():162-70. PubMed ID: 782964
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments.
    Bottex C, Burckhart MF, Fontanges R.
    Arch Virol; 1981 Jun 15; 70(2):83-9. PubMed ID: 7332493
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study.
    Jennings R, Smith T, Potter CW.
    Med Microbiol Immunol; 1981 Jun 15; 169(4):247-58. PubMed ID: 6268957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.